Serotonin (5-HT) uptake sites were mapped by autoradiographic means with PH]cyano-imipramine , the 5-HTIA receptor with [3HJ8-hydroxy-2-[di-n-propyl-amino]tetralin ([3HJ8-0H-DPAT), and the 5-HTz receptor with both pH]ketanserin and {l251]1ysergic acid diethylamide ([lZ5IJLSD) in eight nonneurologic controls and 10 cases with a diagnosis of schizophrenia. In the striatum, there was a marked heterogeneous patterning of 5-HT uptake sites that corresponded to the striosomallmatrix campartmentalization of the striatum. This organization was not matched with an equally heterogeneous pattern � either 5-HTz or 5-HTIA receptors. For the isocortex, a general organizational scheme was observed with the 5-HTIA receptor expression high in the external laminae and deep laminae, but 5-HT2 receptor expression was higher in the internal laminae. There was a laminar distribution of 5-HT uptake sites that approximated the cambined distributions of the 5-HTIA receptor and the 5-HT2 receptor. In the parahippocampal gyrus and hippocampus, the distribution of 5-HT uptake sites was camplementary to the distribution of 5-HTIA and 5-HT2 receptors. In schizophrenic cases, there was a large increase in the number and altered striosomallmatrix organization of 5-HT uptake sites in the striatum. There was also an increase in the numbers of 5-HT2 receptors in the nucleus accumbens and ventral putamen of the schizophrenics. The number of 5-HTIA receptors was not modified. There was a marked reduction in 5-HT uptake sites in the external and middle laminae of the anterior cingulate, frontal cortex, and posterior cingulate, and no changes were observed in the motor cortex, temporal cortex, or hippocampus. Increased numbers of 5-HTIA receptors were found in the posterior cingulate, motor cortex, and hippocampus. Serotoninz receptors were substantially elevated in the posterior cingulate, temporal cortex, and hippocampus, but not in the frontal, anterior cingulate, or motor cortices. Examination of the temporal lobe and hippocampus of a group of nonschizophrenic suicides (n "" 8) indicated the alterations in 5-HT system in the limbic regions of the striatum, the limbic cortex, and hippocampus of the schizophrenic cases may be disease specific. 
antipsychotics have affinity for both DA and 5-HT receptors , or selective (e. g., risperi done, setoperone, and ritanserin) serotonergic prop erties (Castelao et al. 1989; Vinar et al. 1989) . Direct evi dence for changes in the levels of 5-HT or density of 5-HT receptors in the brains of schizophrenics has been difficult to obtain. Although some groups have reported changes in levels of 5-HT in the cortex of schizophrenic cases, the only replicable finding has shown increased 5-HT and/or 5-hydroxyindoleacetic acid (5-HIAA ) in the putamen and globus pallidus Farley et al. 1980; Korpi et al. 1986 ). However, these findings were not supported by the earlier findings of Joseph and associates (1979) and Winblad and associates (1979) , who determined that the most affected region was the hippocampus. Some of the variability in the results of these studies may be related to the fact that a significant number of schizophrenics attempt suicide (Roy 1984) and reduced concentrations of forebrain 5-HT content and numbers of the high-affinity 5-HT transport (up take) sites have been reported in the brains of suicide victims (Crow et al. 1984; Gross-Isseroff et al. 1989; Stan ley et al. 1982) .
The physiologic actions of 5-HT appear to be medi ated by its interaction with three general classes of receptors: 5-HT1, 5-HT2, and 5-HT 3 (for review see, Frazer et al. 1990 ). The density of 5-HT2 receptors, la beled with [3H]lysergic acid diethylamide ([3H]LSD) or [3H] ketanserin, has been shown to be reduced (Ben nett et al. 1979; Mita et al. 1986) , unchanged, or in creased (Whitaker et al. 1981; Reynolds et al. 1983) in the frontal cortex of schizophrenic cases. Again, vari ability in results may be caused by the inclusion of in dividuals whose death occurred by suicide, as there have been reports of increased densities of 5-HT recep tors (Stanley and Mann 1983; Mann et al. 1986; Arango et al. 1990; Arora and Meltzer 1989a) and decreased den sities (Crow et al. 1984; Gross-Isseroff et al. 1990 ) for suicide cases. Recently, Hashimoto and associates (1991) reported an increase in 5-HT1A receptors in the frontal and temporal cortex of schizophrenic cases. However, such changes have also been observed in pa tients committing suicide (Dillon et al. 1991) . Conse quently, it is unclear to what extent alterations in the 5-HT system in schizophrenic cases is disease specific.
Receptor autoradiography can be a particularly use ful tool for exploring the altered expression of trans mitter systems in brains of patients with neuropsy chiatric disorders (Joyce et al. 1988 (Joyce et al. , 1992 . Studies that directly explore the relationship between the distribu tion of 5-HT uptake sites and 5-HT receptors in human brain by using autoradiographic means have not been published. Moreover, much of the research on the receptor disturbances in schizophrenia predates the de velopment of radioligands selective for subtypes of the 5-HT receptor, and of radioligands that can selectively NO.4 label the uptake site for 5-HT located on 5-HT terminals. To determine whether alterations in the 5-HT system can occur in schizophrenic cases, the autoradiographic mapping of 5-HT uptake sites, 5-HT 1 A and 5-HT! receptors sites, was examined in tissue sections ob-I tained from 10 subjects with a diagnosis of schizophre nia and eight cases of nonschizophrenic suicide and compared to those of eight controls. The distribution of high-affini ty uptake sites for 5-HT was mapped with the compound [3H]cyano-irnipramine ([3H]CN-IMI) (Joyce et al. 1992; Kovachich et al. 1988 ), the 5-HTIA receptor of the 5-HT 1 family with [3H]8-hydroxy-2-[di n-propyl-amino]tetralin ([3H] 8-0H-DPAT) (Pazos eta!. 1987a) , and 5-HT2 receptors with both [3H]ketanserin (Pazos et al. 1987b ) and [ 1 2 5I]LSD (Engel et al. 1984) .
MATERIALS AND METHODS

Human Autopsy Tissue
Whole brain hemispheres were obtained from the Brain Tissue Resource Center of McLean Hospital, Harvard University, Boston, Massachusetts and from the Neu· ropathology Section, Clinical Brain Disorders Branch of the National Institute of Mental Health, Bethesda, Maryland. Brain tissues were taken from 10 subjects with a diagnosis of schizophrenia and eight cases of nonschizophrenic suicide (Table 1) . In all cases the diagnosis of schizophrenia was confrrmed by two in· dependent clinicians using DSM-III-R criteria. Deter· mination of drug consumption was based upon retro spective analysis of case reports and toxicology screening. One schizophrenic case had a prefrontal 10-botomy and had taken antiseizure medicine. On the basis of interviews with the family or close relatives, the nonschizophrenic suicide cases were identified as not having a history of schizophrenia and a probable history of affective illness. One patient died from suf· focation while asleep; high levels of ethanol were sub sequently found at autopsy. This patient had a history of manic-depressive illness but was not judged to have committed suicide. The postmortem interval (PMI), de termined for all cases as the time between death and initiation of autopsy procedures, varied from 2 to 29 hours.
In all cases where tissue was provided by sources outside the Hospital of the University of Pennsylvania, the tissue was frozen at autopsy and stored at -BO°C until processed for autoradiography. Tissue from the two cases with a diagnosis of suicide was obtained from the Medical Examiner's office of the City of Philadel· phia (H.M. Mirchandani, Chief Medical Examiner) and the tissue was frozen at autopsy by one of the authors (JNJ). Brain tissue from six age-matched controls was obtained at autopsy (PMI 6 to 24 hours) from the Hos- In all cases the tissue had been frozen at autopsy and stored at -BO°C until processed for autoradiography. Cases were obtained from Hospital of the University of Pennsylvania (HUP), St. Elizabeths Hospital, National Institute of Mental Health (NIMH), McLean Hospital (Mclean) or the Medical Examiner's office, City of Philadelphia (ME) as detailed in Materials and Methods. The mean ± standard deviation is given for the age and PM! for the control, schizophrenia, and suicide/affective illness groups.
( +) Indicates positive for drugs with toxicology screen. ( -) Indicates negative for drug with toxicology screen.
• Prefrontal lobotomy. b Diagnosis of manic-depressive, suffocation was not a suicide.
pita! of the University of Pennsylvania O. Trojanowski, Director of Medical Pathology), rapidly frozen at -40°C, and stored at -80°C. Two additional control cases were obtained from the Medical Examiner's office of the City of Philadelphia, rapidly frozen at -40°C, and stored at -80°C. The control group was composed of individuals who died of natural or accidental causes and had no history of neurologic or psychiatric disease. Gross pathology of the control brains at autopsy ap peared normal. There were no significant differences in the mean age or PM! between the controls, schizo phrenic cases, or nonschizophrenic suicide cases.
For the control and schizophrenic cases, coronal slabs at three anterior-posterior levels of the brain were sectioned and processed for receptor autoradiography.
The anterior section (Fig. lA) included the head of the caudate, rostral putamen, anterior cingulate (area 24), premotor (area 6), and frontal cortex (area 9, not includ ing frontal pole). The midcoronal level contained the caudate, putamen, globus pallidus, and frontal cortex (Fig. 18) . The posterior level included the precentral cortex (areas 4 and 23), postcentral cortex (areas 1 and 5), temporal cortex (Brodmann's 22, 41, 42 and 20,21, 37, not including rostral pole), posterior cinguiate, para hippocampus, and hippocampus (Fig. lC) . In all con trol and schizophrenic cases, the coronal levels were matched for rostral-caudal position. For the suicide cases, coronal levels containing the hippocampus with the temporal and parietal cortex solely were used. For autoradiographic experiments, the brains were sec tioned at 20 J..L m in a Upshaw 1800-N cryotome at -25°C, thaw-mounted onto gelatin-subbed slides, . Abbreviations: area 6, pre motor; area 24, anterior cingu late; area 9, prefrontal; area 4, motor cortex; area 23, cingulate cortex; areas 1 and 5, somatosen sory; C, caudate nucleus; CAl CA 4 , subnelds of the hippo campus; H, parahippocampus and hippocampus; P, putamen; T, temporal cortex.
A B dried at ODC under reduced pressure, and stored at -80DC until further use in the experiments. Every 20th section was retained for Nissl staining.
Radioligand Protocols
Two radioligands were utilized to label 5-HT2 receptors in tissue sections. The protocol for [3H]ketanserin label ing of 5-HT 2 receptors was adapted from that of Pazos and associates (1 987b) and the procedure for [125I]LSD labeling of 5-HT 2 receptors was modified from that of Engel and associates (1 984) . Information from the use of both radioligands was utilized to address issues of the specificity for [l25I]LSD labeling of 5-HT2 receptors. Tissue sections were preincubated for 15 minutes at room temperature in the incubation buffer. Sections were incubated with 2 nmollL [3H]ketanserin (61 Cil mmol; DuPont New England Nuclear) in a buffer con taining 0.17 mollL Tris, pH 7.7, for 2 hours at room tem-D perature. Adjacent sections were incubated similarly but contained 1 f,lmollL mianserin for the defInition of nonspecific binding. Slide-mounted sections were washed two times for 5 minutes each at 4 DC and briefly rinsed in H20 before drying. Alternating sets of slide mounted tissue sections were incubated with 200 pmollL (or in some regions 200 pmollL, 700 pmollL, 900 pmollL, 1.1 nmollL, and 1.9 nmollL) [125I]LSD (2200 Ci/mmol; DuPont New England Nuclear) in a buff er containing 50 mmollL Tris pH 7.4, 10 f,lmollL sui· piride, 1 f,lmollL tripolidine, and 1 f,lmollL prazosin. Ad jacent sections were incubated similarly but contained 1 f,lmollL ketanserin for the defmition of nonspecihc binding. To labelS-HTlA receptors, the procedure of Pazos and associates (1987a) was followed with minor mod ifications (Hensler et al. 1991) . The slide-mounted tis sue sections were preincubated for 30 minutes in the incubation buffer. The sections were incubated with 2 nmollL [3H]8-0H-DPAT (158 Ci/mmol; DuPont New England Nuclear) in a buffer containing 4 mmollL Ca02, 0.17 mollL Tris-HCl buffer, 0. 01% ascorbic acid, pH 7.6, and 10 IlmollL pargyline. Adjacent sections were incubated similarly but contained 5 IlmollL 5-HT for the defmition of nonspecifIc binding. Incubations were carri ed out in a light-proof room for 1 hour at 22°C, washed twice for 5 minutes at 4°C in buffer, and washed for 10 seconds in H20 at 4°C.
To visualize the 5-HT uptake sites located on 5-HT terminals, the radioligand [3H]CN-IMI was used (Kovachich et al. 1988; Joyce et al. 1992 
Data Analysis
The illuminated image of each autoradiograph was col lected by a video camera connected to an IBM AT-based image-analysis system (DUMAS, Drexel University, Philadelphia, P A). Because of nonlinearities in the fIlm and image array processor, these original grey values were not a linear function of the concentration of radi oligand. Tritium-embedded plastic standards contain ing high concentrations of tritium were calibrated Serotonin and Schizophrenia 319 against 1 25I-containing tissue standards and used to transform the original grey value of each pixel to a linear function and expressed as the quantity of 1 25I-radio ligand bound (Artymyshyn et al. 1990 ). The digitized images of the autoradiographs of total and nonspecifIc binding were displayed, the region of interest outlined, and the density of bound radioligand displayed for the region. NonspecifIc binding was subtracted from total binding to obtain specifIc binding. The tissue sections used for the autoradiographic image were stained for Nissl after the development of the autoradiographic im ages, making them available for the visualization of brain nuclei. In addition, every 20th section directly processed for Nissl staining was used to clarify anatomic boundaries. The autoradiographic image was viewed in one frame and the histologic material in the other to facilitate accurate analysis of brain regions. Regions of the cortex were identifIed using the atlas of Nieuwen huis and associates (1978) . The regions of the parahip pocampus, including entorhinal cortex and subfIelds of the hippocampus were identifIed with the aid of the atlas of Amaral and Insausti (1990) . For the detailed mapping of [3H]CN-IMI binding in the striatum of con trol and schizophrenic cases additional information was obtained. Methods previously described for measur ing the patch and matrix compartment-related binding of radioligands were used to delineate the pattern of [3H]CN-IMI binding in striatum (Joyce et al. 1992) . Briefly, microzones high in the density of binding sites and the region surrounding the microzones (low in den sity) were outlined in four regions of the striatum (dor sal caudate nucleus, dorsal putamen, nucleus accum bens, ventral putamen) for at least four serial sections. The average density of the binding in the microzones and "surround" was determined for each striatal region.
For mapping studies a minimum of four sections per level were analyzed by region of brain. Average values were pooled for all cases by disease (treatment condition). Both hemispheres were available for only a few cases. For this reason, each hemisphere was treated as an independent sample for analysis of diff er ences. Differences in the binding of [3H]ketanserin, [1 2 5I]LSD, [3HJ8-0H-DPAT, and [3H]CN-IMI between regions within disease groups and between disease groups were determined by two-factor analysis of vari ance with brain region as the repeated measure. Post hoc paired comparisons were tested for signifIcance of difference using the method of Duncan (Snedecor and Cochran, 1967) . Because fewer regions of brain were available for the suicide group, post-hoc paired com parisons were limited to control versus schizophrenia and control versus suicide.
Materials
Drugs were obtained from the pharmaceutical company of origin or from commercial sources. All radio ligands, range 0.7 to 1.5 nmoIlL), 0. 6 nmollL (range 0.4 to 1.5 nmollL) and 0.14 nmol/L (range O.OB to 0.15 nmol/L). Compari son of the distribution of the radioligands indicated a unique pattern for each site in control brains. In the fol lowing sections, results obtained for the control group will be compared to those obtained from the other ex perimental groups for the striatum, regions of cortex, and the parahippocampal region (including hippo campus).
Striatum
The number of [3H]CN-IMI binding sites in the stria tum of the control group was 5-to 10-fold higher than in any region of cortex (p < .05). The highest number of sites was found in the putamen, with values sig nifi.cantly higher than in the caudate or nucleus accum bens (p < .05; Fig. 2 ). The binding sites were particu larly evident in the ventral putamen (Fig. 3A) . As shown in Figure 3A , the topography of [3H]CN-IMI binding sites in the putamen was patchy with regions of dense binding (microzones) surrounded by regions of less dense binding (Table 2) . Microzones of dense binding were also visible in the caudate nucleus but less appar ent. For the control group, the number of 5-HTIA re ceptors was considerably lower in the striatum than in the cortex (by 9-to 10-fold), and was homogeneously distributed ( numbers of 5-HT uptake sites (between group effects, p < .01 all regions) and 5-HT2 receptors (between group effects, p' .001; nucleus accumhens and putamen). For the schizophreni grou p 5-HT uptake sites were signmcantly higher in the puta men than the caudate or nucleus accumhens (between regions p < .05) and 5-HT2 receptors were signmcantly higher in th nucleus accumbens and putamen than in the caudate (be tween regions, p < .05). Abbreviations: Nuc Acb, nucleus ac cumbens. Between group differences are indicated by a sin gle asterisk, signifIcant diff erences between regions for contre group by double asterisk, and Significant differences betweel regions for schizophrenic group by triple asterisk. The diagram of the striatum shows the location of the regions analyzed. Note larger zones of higher density of (3HlCN-IMI sites in the schizophrenic case in the ventral striatum and the existence of "microzones" of dense binding in the dorsal striatum (caudate nucleus and putamen) of the schizophrenic but not the control case. In contrast, 5-HT 2 receptors are increased in the ventral striatum (nucleus accumbens and ventral puta men). The pseudocolor coding for the density of binding sites at a single concentration is represented by red as the highest.
Abbreviations: Nuc Acb, nucleus accumbens.
found. Similar results were obtained with [125IILSD (data not shown). The number of sites labeled with a single concentration of [125IILSD was higher in the stri atum than that found in the hippocampus and entorhi nal cortex but lower than that observed in most regions of cortex (p < .05).
The striatum of the schizophrenic cases showed a diff erent pattern of binding as compared to controls for PRleN-IMI to 5-HT uptake sites and of [3H]ketanse rin binding to 5-HT2 sites (Figs. 2 and 3). The number ofS-HT uptake sites was elevated in the striatum of the schizophrenic group by 60% to 100% as compared to the control group (p < .01). As depicted in Figure 3A , the typical pattern in the control cases of highest binding in the ventral putamen still existed in the schizophrenic cases. However, the microzones of binding were sig nifIcantly denser and greater in size (Table 2 ). In addi- NEUROPSYCHOPHARMACOLOGY 199 3 -VOL. 8, NO.4 The schizophrenics showed reduced num bers of 5-HT uptake sites in laminae I-III of the anterior cingulate cortex (between groups, p < .01) and of laminae I-IV of prefrontal cortex (between groups, p < .01) as compared to the control group. The number of 5-HT 1 A receptors was elevated in the laminae V-VI of the an terior cingulate cortex as compared to the control group (between groups, p < .01). For the control group, 5-HT uptake sites were signifIcantly higher in lami nae I-III than laminae V-VI (between regions, p < .01), 5-HT 1 A receptors were higher in laminae I-II than III-VI (be tween regions, p < .01), and 5-HT2 re ceptors higher in laminae III than all otheriaminae (p < .001). For the schizo phrenic group, 5-HT 1 A receptors were higher in laminae I-II than III-VI (be tween regions, p < .01), and 5-HT2 re ceptors higher in the intermediate lam inae (I1Ia,b,c, or III-IV) than all other laminae (p < .001). Between group diff er ences are indicated by single asterisk, signifIcant differences between regions for control group by double asterisk, and signifIcant differences between re gions or schizophrenic group by triple asterisk.
ANT CING CORTEX PREFRON' 'TAL CORTEX
5-HT Uptake sites 5-HT Uptake sites Figure 1C The schizophrenic group showed reduced numbers of 5-HT uptake sites in the laminae I-III of posterior cingulate cortex (p < .001) and an eleva ti on in the deep laminae of the motor cortex (p < .01) as compared to the control group. The schizophrenic group showed elevated numbers of 5-HTIA receptors in the larnmae III and V-VI of posterior cingulate cortex (p < .01) and all laminae of motor cortex (p < .001) as compared to the control group. The number of 5-HT2 receptors was elevated in the schizophrenic group in laminae III of posterior cingulate cortex (p < .001) as compared to the control group. Within the cingulate cortex, the control group showed higher numbers of 5-HT uptake sites for laminae I-II than IIIa,b,c, which is greater than laminae V-VI (between regions, p < .01). Serotonin l A receptors were higher in laminae I-II than IIIa,b,c, which is greater than lami nae V-VI (between regions, p < .01), and 5-HT2 receptors higher in laminae III than all other laminae (p < .001). For the schizophrenic group, 5-HTIA receptors were higher in laminae I-II than III-VI (between regions, p < .01), and 5-HT2 recep tors higher in laminae IIIa,b,c than all other laminae (p < .001). Within the motor cortex, the control group showed lower numbers of 5-HT uptake sites for laminae V-VI than all other laminae (between regions, p < .01). SerotoninlA receptors were higher in laminae I-II than IIIa,b,c, which is greater than laminae V-VI (between regions, p < .01). For the schizophrenic group, 5-HTIA receptors were higher in laminae I-II than IIIa,b,c, which is greater than laminae V-VI (between regions, p < .01). Abbreviations: CINGULA TE CORTEX, posterior cingulate cortex. Between group differences are indicated by single asterisk, signifIcant differences between regions for control group by double asterisk, and signifIcant differences between regions for schizophrenic group by triple asterisk.
TEMPORAL CORTEX
5-HT Uptake sites Figure 1C The schizophrenic group showed elevated numbers of 5-HT2 receptors in laminae III-IV of the temporal cortex (between group, p < .(01). Within the temporal cortex, the control group exhibited higher numbers of 5-HT uptake sites for laminae I-II than ill -IV, which was greater than laminae V-VI (between regions, p < .01). Serotonin l A receptors were higher in laminae I-II than V-VI, which is greater than laminae III-IV (between regions, p < .01), and 5-HT2 receptors were higher in laminae ill -IV than all other laminae (p < .001). For the schizophrenic group, 5-HTIA receptors were higher in laminae I-II than V-VI, which is greater than laminae III-IV (between regions, p < .01), and 5-HT2 receptors were higher in laminae III-IV than V-VI, which is higher than laminae I-II (p < .01). Within the entorhinal cortex, the control group showed higher numbers of 5-HT uptake sites in laminae I-II than III-IV, which is greater than laminae V-VI (between regions, p < .01). SerotoninlA receptors were lower in laminae III-IV than I-II or V -VI (between regions, p < .01). For the schizophrenic group, 5-HT up' take sites were higher in laminae I-IV than V-VI (between regions, p < .01), 5-HTIA receptors were lower in laminae ill -IV than I-II or V-VI (between regions, p < .01). Between group differences are indicated by single asterisk, significant diff er· ences between regions for control group by double asterisk, and significant diff erences between regions for schizophrenic group by triple asterisk.
spicuous in the anterior cingulate (laminae I > laminae V-VI; p < .01), frontal (laminae I-II > III-IV> V-VI; p< .01), posterior cingulate (laminae I > III-IV> V-VI; P < .01), and parietal cortices (data not shown) and least distinct in motor cortex (laminae I-II > V-VI; p < .01). In most of the cortices the pattern of [3H]8-0H-DPAT binding of 5-HT 1 A receptors closely followed that of the 5-HT uptakes sites with [3H]8-0H-DPAT binding to 5-HT 1 A receptors highest in the upper laminae, be ing more than twofold greater in number than the mid dle and inner laminae (Figs. 4 and 5) . This was evident in the anterior cingulate (laminae I > laminae V -VI; P < .01), frontal (laminae I-II > III-IV = V-VI; P < .01), posterior cingulate (laminae I > III-IV > V-VI; P < .01), and parietal (laminae I > III-IV> V-VI; P < .01, data not shown) cortices, but less so for the motor cortex �aminae I-II> III > V-VI; P < .05). The labeling of 5-HTz receptors with [ 1 25I]LSD was more than twofold higher in the middle laminae (layers III and IV) than the deep laminae and slightly higher in the deep than the superfIcial laminae of anterior cingulate (p < .001), frontal (p < .001), posterior cingulate (p < .05), and pa rietal (p < .05) cortices. In motor cortex the pattern of 5-HTz receptors did not differ by laminae (Fig. 5) .
For the schizophrenic cases, binding of [3H]CN lMI to 5-HT uptake sites was reduced by 51% to 76% as compared to control cases in the external and mid dle laminae of some cortical regions, including the an terior cingulate (schizophrenic < control; p < .01; Fig.  4 ), 'frontal cortex (schizophrenic < control; p < .01; Fig.  4) , and posterior cingulate (schizophrenic < control; p < .01; Fig. 5 ), but not in the motor cortex or parietal cor tex (or temporal cortex, see below). Consequently, there was no signifIcant difference among laminae of the an te rior cingulate, frontal cortex, and posterior cingulate cortices of the schizophrenic group. Comparison of the schizophrenic to the control group demonstrated bet ter than a threefold elevation in the binding of [3H]8-OH-DPAT binding to 5-HT 1 A receptors in the cingu late (schizophrenic> control; p < .01; Figs. 4 and 5) and motor cortex (schizophrenic> control; p < .001; Fig. 5 ) but not in the frontal (Fig. 4) , or parietal cortices (or tem poral cortex, see below). In the anterior cingulate, the increase was signifIcant only for the deep laminae (p < .01), whereas both middle and deep laminae of the posterior cingulate showed better than twofold higher numbers of 5-HT 1 A receptors (p < .01) in the schizo phrenic group as compared to the control group. All laminae of the motor cortex show two-to threefold in creases in binding of PH]8-0H-DPAT (p < .01) in the schizophrenic group as compared to the control group. However, the laminar arrangement of 5-HT 1 A recep tors was not altered in any cortical region of the schizo phrenic cases. [ l 2SI]LSD binding to 5-HTz sites was also elevated in the middle laminae of the posterior cingu late (schizophrenic> control; p < .001; Fig. 5 ) but not in the frontal, anterior cingulate, or motor cortices.
Temporal Cortex and Hippocampus
In most regions of the temporal lobe of the control cases, the pattern of 5-HT uptake sites was similar to that in frontal cortex with the external laminae exhibiting the highest binding of [3H]CN-IMI (laminae I-II> V-VI;
Serotonin and Schizophrenia 325 p < .01). In the superior, middle, and inferior lobes of the temporal cortex, the binding of [3H]8-0H-DPAT was trilaminar with the binding highest in the external laminae and lowest in the middle laminae (laminae I-II > V-VI> III; p < .01; Fig. 6 ). As in the frontal cortex, [ l Z51]LSD-Iabeled 5-HTz receptors were highest in number in the middle laminae (laminae III-IV> I-II = V-VI; P < .01; Fig. 6 ). In the medial temporal lobe of the control cases (entorhinal cortex) [3H]CN-IMI bind ing to 5-HT uptake sites was most abundant in number in the external laminae and the relative numbers simi lar to other regions of temporal cortex (laminae I-II > V -VI; P < .01; Fig. 6 ). In contrast, the laminar distribu tion of 5-HTz receptors in this same region was in distinct with relatively low numbers of sites when com pared to other regions of temporal cortex (Fig. 6) . There appeared to be a reverse pattern of 5-HT uptake sites and 5-HT receptors, which was particularly evi dent for the distribution of 5-HT lA receptors as com pared to 5-HT uptake sites (Fig. 7) . Regions of the para hippocampus and hippocampus that were low in the number of [3H]CN-IMI-Iabeled sites (Figs. 7 A and 9) , such as the subiculum and CA l subfIeld, were highest in the number of 5-HTIA receptors labeled with [3H]8-OH-DPAT (Figs. 7C, 8B, and 9) . Conversely, in the den tate gyrus (DG), relatively high numbers of 5-HT up take sites and low numbers of 5-HTIA receptors were apparent. Thus, [3H]CN-IMI-Iabeled sites were sig nifIcantly higher in the DG than the CA 3 or CA l sub fIelds (p < .01), and [3H]8-0H-DPAT binding was higher in the CA l than DG (p < .01) . The distribution of 5-HTz receptors largely paralleled that of 5-HTIA receptors in the main body of the hippocampus (Figs. 8A and 9), but not in the rostral hippocampus (Fig. 78) .
In the rostral hippocampus, low levels of [ l Z51]LSD binding were present and inverse patterns to that of [3H]8-0H-DPAT binding. In contrast, in the main body of the hippocampus relatively high numbers of 5-HTIA receptors and 5-HT 2 receptors were found in the pyramidal layer of the CAl subfIeld, lower in stri- represented by red as the highest. Note that in the entorhinal cortex, the density of receptors is low and the number of uptake sites relatively high, but in the CA 1 subfIeld of the hippocampus, the opposite pattern exists with [ 3 H18-0H-DPAT-labeled 5-HTIA receptors high in number and 5-HT uptake sites low. However, 5-HT2 receptors in the rostral hippocampus were low in number and the pattern inverse to that of [ 3 Hj8-0H-DPAT binding (this fIgure) but overlap with 5-HTIA receptors in more caudal regions of the hippocampus (see Fig. 8 ). Abbreviations: EC, entorhinal cortex; Hi, hippocampus; TC, temporal cortex. 
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.E 11/ '0 E Figure 1D . The schizophrenic group exhibited elevated numbers of 5-HT2 receptors in all hippocampal subfIelds (be tween groups, p < .01) and 5-HTlA receptors in the DC (between groups, p < .01) of the hippocampus as compared to the control group. The suicide group showed increases in 5-HTlA receptors in subfIelds CAl-CA 3 as compared to the control group (between groups, p < .01). The control group had higher numbers of 5-HT uptake sites in DC than CA 3 , which is higher than CAl, higher numbers of 5-HTlA receptors in CAl than CA 3 , which is higher than DC, and higher numbers of 5-HT2 receptors in CAl than all hippocampal subfIelds (between regions, p < .01). The schizophrenic group showed fewer 5-HT uptake sites in the CAl than all other hippocampal subfIelds, fewer 5-HT lA receptors in DC than all other hippocam pal subfIelds, and higher numbers of 5-HT2 receptors in CAl than all hippocampal subfIelds (between regions, p < .01). The suicide group demonstrated higher numbers of 5-HT uptake sites in DC than CA 3 , which is higher than CAl, fewer numbers of 5-HTlA receptors in DC than all hippocampal subfIelds, and higher numbers of 5-HT2 receptors in CAl than all hippocampal subfIelds (between regions, p < ,01). The number of sites for the pyramidal cell layer of CAl (CAl PYR) and CA 3 (CA 3 PYR) is shown, and the granule cell layer of the dentate gyrus (DC CRAN). Between group differences are indicated by single asterisk, signifIcant differences between regions for control group by double asterisk, and signifIcant diff erences between regions for the schizophrenic (left panel) or suicide (right panel) groups by triple asterisk. (Fig. 6 ), entorhinal cortex (Fig. 6 ), or hippocampus (Fig. 9 ) of the schizophrenic cases as com pared to control cases. In contrast, 5-HT uptake sites were signifIcantly reduced in number for the suicide group as compared to the control group within the tem poral cortex (suicide < control; p < .01; Fig. 10 ) and en torhinal cortex (suicide < control; p < .01; Fig. 10 ). The reduction in the suicide cases was signifIcant only for the upper and middle laminae of the temporal cor tex (p < .01). Although [3H]8-0H-DPAT binding to 5-HTIA receptors was unchanged in the temporal cor tex of schizophrenics (Fig. 6 ) and suicide cases (Fig. 10) as compared to the controls, there was an elevation in the entorhinal cortex of the suicide cases as compared to controls (suicide> control; p < .001; Fig. 10 ). The in crease in [3H]8-0H-DPAT binding was signifIcant for all laminae of the temporal cortex (p < .001). The num ber of 5-HT l A receptors was increased in the hip pocampus of schizophrenic and suicide cases as com pared to controls (Fig. 9) , but the patterns of increased binding were not similar in the schizophrenic and sui cide cases. The increase in 5-HTIA receptors was sig nifIcant for the DG of the schizophrenic group as com pared to the control group (p < .01) and for the CAI-CAJ subfIelds of the suicide group as compared to the control group (p < .01). The schizophrenic cases showed an elevation in 5-HT2 receptors (Fig. 8) in the middle laminae of the temporal cortex (schizophrenia> control; p < .05; Fig. 6 ) and hippocampus as compared to controls (schizophrenia> control; p < .01; Fig. 9 ) but not in the entorhinal cortex (Figs. 6 and 8) . Saturation assays of the binding of [ 1 2 5I]LSD to 5-HT2 receptors in the temporal cortex of the schizophrenic cases and controls indicated that the differences were due to a change in the number of sites (Bmax 187 ± 31 fmols/mg protein for control; Bmax 252 ± 37 fmols/mg protein for NEUROPSYCHOPHARMACOLOGY 199 3 -VOL. 8, NO. 4 schizophrenia; p < .01) and not in the affinity of the 5-HT2 receptors for [ 1 2 5I]LSD binding (1.3 ± 0.4 nmollmg for control, 1.9 ± 0.6 nmollmg for schizophre nia) . The suicide cases did not show alterations in the binding of [ 1 2 5I]LSD to 5-HT2 receptors as compared to controls (Figs. 9 and 10) .
DISCUSSION
Striatum
The distribution of 5-HTIA and 5-HT2 receptors has been well characterized in human brain (Dillon et al. 1991; Hoyer et al. 1986; Pazos et al. 1987a Pazos et al. , 1987b Schotte et al. 1983 ) and nonhuman primate brain (Lidow et al. 1989 ). We obtained a Kd value for [3H]8-0H-DPAT labeling of 5-HTIA receptors that was only slightly lower than values obtained using sections of rat brain (Verge et al. 1986 ). Other investigators have also found a lower Kd for the binding of [3H]8-0H-DPAT to 5-HT l A receptors in sections of rat or human brain than that obtained with membrane preparations (Dillon et al. 1991; Hashimoto et al. 1991 (Hashimoto et al. 1991) . This suggests that the linkage to G proteins is functionally intact in tissue sections (De Vivo and Maayani 1990) . As expected, we obtained very low binding of [3H]8-0H-DPAT to 5-HTIA receptors in the striatal complex (Pazos et al. 1987a Biegon and associates (1986) and Lidow and associates (1989) , but lower than that reported by Hoyer and associates (1986) . The � value we determined for [ l 2 5I]LSD binding to tissue sections is also similar to that reported by Arango and associates (1990) for hu man cortical membranes and Engel and associates (1984) for rat cortical membranes. The number of sites labeled with [ 1 2 5I]LSD or [3H]ketanserin in the striatum was signifIcantly less than that labeled in the frontal cortex. This is consistent with previous studies that show two to threefold higher densities in the isocortex than in the basal ganglia and hippocampus (Pazos et al. 1987b; Schotte et al. 1983 ). We did not fInd a heterogeneous pattern of 5-HTIA or 5-HT2 receptors in the striatum, unlike that for DA receptors (Joyce et al. 1986 (Joyce et al. , 1988 (Joyce et al. , 1991 , muscarinic receptors (Lowenstein et al. 1990) , and 13-adrenergic receptors (Joyce et al. 1992) .
Autoradiographic studies of the distribution of 5-HT uptake studies in human brain have been pub lished using [3H]imipramine (Cortes et al. 1988 ; Gross- .001). Within the temporal cortex, the suicide group showed higher numbers of 5-HT uptake sites for laminae I-IV than V-VI (between regions, p < .01).
SerotoninlA receptors were higher in laminae I-II than V-VI, which is greater than laminae III-IV (between regions, p < .01), and 5-HT2 receptors were higher in laminae III-IV than all other laminae (p < .01). Within the entorhinal cortex, the suicide group showed higher numbers of 5-HT uptake sites in lami nae I-IV than laminae V-VI (between regions, p < .01). SerotoninlA receptors were lower in laminae III-IV than I-II or V-VI (between regions, p < .01). Be tween group differences are indicated by single asterisk, signifIcant differences between regions for control group by double asterisk, and signifIcant diff er ences between regions for suicide group by triple asterisk.
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isseroff and Biegon 1988) and [3H]desmethylimipra mine ), but the information provided is limited as the radioligands do not selectively labe1 5-HT uptake sites (0' Amato et al. 1987) . Only one study has described the autoradiographic distribution of the selective radioligand [3H]paroxetine in human brain and the regions utilized were quite limited in scope (Cortes et al. 1988 ). The radioligand [3H]CN-IMI does selectively labe1 5-HT uptake sites located on nerve terminals and the cell body (Kovachich et al. 1988) as exemplifIed by the loss of sites with selective lesions of 5-HT cell bodies (Hensler et al. 1991) , and correla ti on with 5-HT levels and other radioligands that label the 5-HT transporter (Kovachich et al. 1988 ). Our results show that the distribution of [3H]CN-IMI binding in human brain was highest in the striatal complex, con sistent with previous reports of [3H]paroxetine bind ing (Laruelle and Maloteaux 1989; Lawrence et al. 1990 ).
LAM INAE
• CONTROL IJ SUICIDE
LAMINAE
The autoradiographs showed a heterogeneous pattern in the striatum, with microzones of dense [3H]CN-IMI binding evident in the ventral striatum, where the dense microzones were 1.5 to 2 times denser than in the areas surrounding the microzones. These microzones were infrequently observed in the dorsal caudate nucleus and dorsal putamen. This corresponds to what has been ob served by 5-HT immunocytochemical demonstration of the serotoninergic innervation of the monkey stria tum (Lavoie and Parent 1990) . The patchy organization of the serotonin uptake sites is related to an intrinsic neurochemical organization of the striatum, termed the striosomal and matrix compartments, which can be related to heterogeneities in the binding of a num ber of markers for transmitter systems (Joyce et al. 1988 (Joyce et al. , 1992 .
We observed signifIcant changes in the pre-and postsynaptic components of the 5-HT system in the schizophrenic striatum. A large increase in the num ber of 5-HT uptake sites was observed in all regions of the striatum and two striking changes were observed:
(1) an increase in the number and density of patches in the ventral striatum, and (2) the appearance of patches of dense binding in the dorsal putamen and caudate nucleus. Since we used a concentration of
[3H]CN-IMI approximately three times the Kd (as de termined in control tissue), it was unlikely that the changes observed in the schizophrenic cases were due to changes in the affinity of the radio ligand for the up take sites. The change in the number of uptake sites is consistent with previous evidence that there was an increase in the concentrations of 5-HT and/or 5-HIAA in the putamen of schizophrenic cases Farley et al. 1980; Korpi et al. 1986 ) . Consequently, there may exist a hyperinnervation of schizophrenic striatum by 5-HT afferents including aberrant innervation to the dorsal caudate.
We also observed a substantial increase in the num ber of 5-HT 2 receptors in the schizophrenic cases, but the increases were not in the same regions as those for (Owen et al. 1981) or nucleus accum bens (Mackay et a1. 1978) . Direct comparison of our results with those of previous studies is diffIcult, as non selective radioligands were used, and the regions ex amined may not be comparable to those used in this autoradiographic study. In contrast to our results for 5-HT2 receptors in the schizophrenic group, no change in the number of 5-HTIA receptors was observed in the striatum. We have previously observed in schizo phrenic cases that the dorsal caudate nucleus shows a reduction in the number of DA uptake sites (Joyce et a1. 1988) and an increase in the number of PI adren ergic receptors (Joyce et a1. 1992) . The dorsal striatum also evidenced an increase in patches of binding for
[3H]CN-IMI binding to 5-HT uptake sites. The ventral striatum displays an increase in 5-HT2 receptors, 5-HT uptake sites, an increase in DA 02 receptors (Joyce et a1. 1988) , and PI-adrenergic receptors (Joyce et a1. 1992 ) . The results of this and previous studies (Joyce et a1 . 1988 (Joyce et a1 . , 1992 suggest that the compartmental orga nization of the monoamine systems may be altered in schizophrenic cases. It will be important to determine 1993-VOL. 8, NO. 4 whether the differences between the schizophrenic and control groups in the striatal orgarrization of the DA sys tem, 5-HT system, and noradrenergic system reflect a generalized disturbance in the boundaries of the stri osomal and matrix compartments.
Cortex and Hippocampus
Previous studies have demonstrated that the 5-HTIA receptor represents the major member of the 5-HTI family in all cortical regions and in the hippocampus (Dillon et a1. 1991; Pazos et a1 . 1987a ) . In the cortex, the 5-HTIA receptor shows a different pattern from the 5-HT2 receptor with the 5-HTIA receptor highest in the external laminae and the 5-HT 2 receptor higher in the internal laminae (Dillon et al. 1991; Lidow et al. 1989; Pazos et al . 1987a Pazos et al . , 1987b (Lidow et a1. 1988 ).
The pattern of 5-HTIA receptors that were sampled diff ered in the temporal cortex (superior, middle, and inferior gyri) as compared to the frontal cortex. We de termined that the number of 5-HTIA receptors was more than threefold higher in the upper and deep lam inae than in the middle laminae (see also, Dillon et aI. is also relevant to the studies of 5-HT 2 receptors in hip pocampus which have been reported to be higher in number in the CA1-CA 3 subfIelds and DG than in the subiculum, but signifIcantly lower than the isocortex (Hoyer et al . 1986; Pazos et al. 1987b ) . We found a more dearly differentiated pattern of expression using (Hoyer et al . 1987; Leysen et al . 1987 Leysen et al . , 1988 could contribute to the different fIndings . Although [3H] ketanserin has been the preferred radioligand for the study of 5-HT2 recep tors, it is known to label the monoamine transporter located on synaptic vesicles (Leysen et al. 1987 (Leysen et al. , 1988 and al-adrenergic receptors (Hoyer et al. 1987) , as well as the 5-HT2 receptor, and may not be the most suit In the temporal lobe, the superior, middle, and inferior gyri showed a less obvious overlap. In the entorhinal cortex, the pat tern of 5-HTIA receptors and 5-HT uptake sites con trasted with the low density of 5-HT2 receptors. In the hippocampus there was a contrasting pattern of 5-HT uptake sites, 5-HTIA receptors, and 5-HT2 receptors.
Alterations in Schizophrenia
In contrast to what we found in the striatum, the num ber of 5-HT uptake sites was not increased in any corti cal region of the schizophrenic group. There was, in fact, a marked reduction of sites in the external and mid dle laminae of the anterior cingulate cortex, frontal cor tex, and posterior cingulate cortex but not in the motor cortex, temporal cortex, or hippocampus. One group found reduced numbers of [3H]imipramine sites in the frontal cortex of the right hemisphere of schizophrenics as compared to controls, but no differences for the left hemisphere (Demeter et al. 1989) . In a published ab stract, Laruelle and associates (1 990) reported a reduc tion in [3H]paroxetine binding to frontal cortex in post mortem brains of schizophrenics. There have been no studies that have reported changes in the levels of 5-HT in the frontal cortex or any other cortical region Joseph et al. 1979; Korpi et al. 1986; Win blad et aI. 1979) . In both previous studies using radio ligands to label5-HT uptake sites, it was found that pa tients with a diagnosis of depression (Demeter et al. 1989) or who had committed suicide (Laruelle et al. 1990 ) also had reductions in the number of sites that were similar in magnitude to the schizophrenic cases. This raises the possibility that the changes in the number of 5-HT uptake sites found in this study for the anterior cingulate cortex, frontal cortex, parietal cortex, and posterior cingulate cortex cannot be attributed to schizo phrenia per se, but would be common to many psy chiatric illnesses that have an affective component (Crow et al. 1984; Gross-Isseroff et al. 1989; Stanley et al. 1982; Zubenko et al. 1991 (Lawrence et al. 1990 ) binding in suicide cases for brain regions that we determined were altered in the schizophrenia group (striatum, frontal, cortex, or cingulate cortex). Conse quently, it will be important to examine the speciftcity of the changes in 5-HT uptake sites in schizophrenia and other disorders with an affective component in fur ther studies. In the same schizophrenic group, 5-HT2 receptors were substantially elevated in the posterior cingulate NEUROPSYCHOPHARMACOLOGY 1993-VOL. 8, NO. 4 (middle laminae), temporal cortex (middle laminae), and hippocampus but not altered in the frontal, anteri or cingulate, or motor cortices. Previous studies (Arora and Meltzer 1991 ; Mita et al. 1986 ) reported fmding a de crease in [3H]spiroperidol or [3H]ketanserin binding to 5-HT2 receptors in the frontal cortex of schizophreni cs as compared to controls. They attributed the results to a reduction in the maximum number of 5-HT2 sites and not to a change in the affinity of the compounds for the 5-HT2 sites. It is unclear if these discrepant results reflect the utilization of different radioligands, diff er ent groups of patients, methods of tissue preparation (membrane binding versus autoradiographic methods), or even region of the brain. The region designated as frontal cortex in this study did not include the frontal pole, which was included in the previous studies. Ad ditionally, there were a number of reports that sui cide is related to an elevation in 5-HT2 receptors in the fron tal cortex (Arango et al. 1990; Mann et al. 1986; McKeith et al. 1987; Arora and Meltzer 1989a) . Some of our schizophrenic cases had committed suicide, and this may have contributed to variability in the results of 5-HT2 receptor measurement in frontal cortex.
We found elevations in several regions of the pos t central cortex, including the posterior cingulate (mid dle laminae), temporal cortex (middle laminae), and hippocampus. However, in the medial temporaI lobe the entorhinal cortex was not affected. An examination of 5-HT2 receptor expression in schizophrenia for regions outside the frontal cortex has not been pr evi ously reported. The alterations in 5-HT2 receptor den sity that we observed were unlikely to be due to anti psychotic medication, age, or cause of death. Chroni c administration of classic antipsychotics, such as haloperidol, has been shown not to modify (O'Dell et al. 1990; Wilmot and Szczepanik 1989) , or even decrease (Lee and Tang 1984; Andree et al. 1986 ), the number of 5-HT2 receptors in frontal cortex of rats. In fact, in creases in the density of 5-HT2 receptors could not be induced by any method that reduced 5-HT transmis sion or with chronic treatment with antidepressant drugs (for review, Frazer et al. 1988 ). Gross-Isseroff and associates (1 990) have reported that 5-HT2 receptor density was affected somewhat by age, but in a region speciftc manner. Receptor number was decreased in the frontal cortex and hippocampus and not other cortical or subcortical regions of elderly as compared to young patients. Since the group of schizophrenics that were utilized in this study contained a number of cases that were younger than the control cases and had commit ted suicide, there was the potential concern that the ob served changes might be related to age. Additionally, there were a number of reports that suicide is related to an elevation in 5-HT2 receptors in the frontal cor tex (Arango et al. 1990; Mann et al. 1986; McKeith et al. 1987; Arora and Meltzer 1989a) . Therefore, we exam-ined the 5-HT system in the parietal cortex and tem poral cortex of a group of cases that had committed sui ci de, did not have a diagnosis of schizophrenia, and were of a younger age than the control group . Some diff erences from controls were apparent, but these were not regionally the same as found in the schizophrenic group . No change in the pattern or number of 5-HT2 sites was observed in the temporal cortex (or hip pocampus) of suicide cases as compared to controls. This latter fmding was in agreement with the recent au toradiographic study by Arango and associates (1990) that found increases in 5-HT2 receptors in the frontal cortex, but not the temporal cortex of suicide cases.
We observed increased numbers of 5-HT1A recep tors in those brain regions of schizophrenics that did not show changes in the number of 5-HT uptake sites, including the posterior cingulate and the motor cortex. We also observed increased numbers of 5-HT 1 A recep tors in the hippocampus, but not the entorhinal cor tex. For several reasons, we believe these changes in 5·HT 1 A receptors in the hippocampus to be disease specifIc. First, there was no signifIcant overlap of the regions showing increases in 5-HT1A and 5-HT2 recep tor numbers; thus, there is regional selectivity in the receptor alterations in schizophrenia. Second, although the increase in number of 5-HT 1A receptors in the hip pocampus of the schizophrenics was also observed in the suicide cases, the subfi.elds affected were not the same in the schizophrenic and suicide cases. The in crease in 5-HT 1A receptors was signifIcant for the DG of the schizophrenic group and for the CA1-CAJ sub fIelds of the suicide group. Biegon and associates (Dil lon et al. 1991) have also explored whether 5-HT l A receptor number was altered in suicide cases. Although they observed a tendency for an increase in number in the hippocampus, the only signifIcant fi.ndings related to those cases were that ethanol consumption was high. Consequently, the changes in 5-HT1A receptor num bers associated with schizophrenia are likely to be differ ent from suicide processes. In contrast to other regions of the brain, 5-HT1A receptors in the hippocampus could be modifi.ed by lesions to the 5-HT system and by chronic administration of some antidepressant drugs (Hensler et al. 1991) . Serotonin l A receptors are thought to be located on cells postsynaptic to the terminals in cortical regions and in the hippocampus (Gozlan et al. 1983; Hall et al. 1985) . Administration of tranylcypro mine, but not other antidepressant drugs, can increase the number of receptors in the CA2-CAJ subfi.elds of the hippocampus but not in cortical regions (Hensler etal. 1991) . Whereas some patients in the suicide group had taken antidepressants, there was no evidence that the schizophrenic patients were taking antidepressants or alcohol. Additionally, we did not fi.nd a reduction in 5-HT uptake sites in the regions of the cortex and hi ppocampus where elevations in 5-HT1A receptors Serotonin and Schizophrenia 333 were found. Consequently, the increase in 5-HT1A receptors in the DG of the schizophrenic cases was un likely to be due to drug treatment, response to reduced 5-HT, or inclusion of schizophrenic cases that commit ted suicide . However, caution must be used in inter preting these fmdings; Winblad and associates (1979) have found a reduced 5-HT content in hippocampus of schizophrenic cases. One group has also recently reported that an increase in 5-HT 1A receptor number could be found in the prefrontal cortex and temporal lobe but not in the hippocampus of elderly schizo phrenic cases (Hashimoto et al. 1991) . The study uti lized membranes derived from these regions of brain and so may not be directly comparable to our study. Our data show that 5-HT1A receptors were affected differently from 5-HT 2 receptors in the schizophrenic group and support the view that the elevation in 5-HT receptors in a number of cortical regions was an impor tant fi.nding.
SUMMARY
Our results suggest that in schizophrenia, there are selective changes in the 5-HT system in structures that compose the limbic system including the cortex, hip pocampus, and striatum. These data support the hy pothesis that the 5-HT system plays a role in schizophre nia (Bleich et al. 1988; Meltzer 1989) . Our results show that more than one component of the 5-HT systems is directly altered in schizophrenia, with increased 5-HT receptor number in several limbic regions. A supersen sitive 5-HT system in schizophrenia is suggested by the evidence that compounds with antiserotonergic prop erties have antipsychotic properties (Castelaoo et al. 1989; Meltzer et al. 1989; Vinar et al . 1989 ) . More re cently, Iqbal and associates (1991) examined the re sponse of schizophrenic patients to direct challenge with a 5-HT agonist and found marked worsening of symptoms, also suggestive of a supersensitive 5-HT sys tem. Chronic treatment with many of the atypical an tipsychotics can reduce the number of 5-HT2 receptors (Leysen et al. 1987b; O'Dell et al. 1990; Wilmot and Szczepanik 1989) . It will be important to determine if modifIcation of receptor number in limbic cortex and limbic regions of striatum may be a means by which these drugs can interfere in the development of psy chotic symptoms.
